-
Posts
4,735 -
Joined
-
Last visited
-
Days Won
14
Everything posted by Sunshine State
-
Treba ostati psihofizicki zdrav i prav! :)
Sunshine State replied to kalistenika u rutini's topic in Društvo
Ja vama ne mogu opisati moju trenutnu frustraciju! Od svih mogucih destinacija na kojim sam se mogla zateci, ja se zateknem u Vucicevom kazamatu! 😥 -
Covid-19 / SARS-Cov2 - naučne/medicinske informacije i analize
Sunshine State replied to wwww's topic in Društvo
Mozda AV i nije lud sto drzi respiratore neraspakivane u magacinu: https://www.the-hospitalist.org/hospitalist/article/220301/coronavirus-updates/protocol-driven-covid-19-respiratory-therapy-doing Par zanimljivih opservacija vezano za to sta covid-19 radi plucima - ne kao klasicna pneumonia i akutni respiratorni distress, vec vise kao hipoksija kod high altitude pulmonary edema, pa respiratori podeseni s parametrima za klasican ARDS mogu da naprave vise stete nego koristi. https://mobile.twitter.com/cameronks/status/1247539853186625536 -
"Kaže da je kriv što policijski čas nije bio biti od petka do ponedeljka ali će vevrovatno od sledećeg petka biti tako, jer nas je subota pre podne skupo koštala. Ova odluka je izvesna za Beograd i Niš, ali će se za ostatak Srbije tek odlučiti." Kako nas je skupo kostala jedna subota pre podne?? Oj zivote, sceno iz bugarskog filma, kako ja, pored Nemacke, US i Holandije, zavrsih u ovom trenu ovde?! 😞
-
Covid-19 / SARS-Cov2 - naučne/medicinske informacije i analize
Sunshine State replied to wwww's topic in Društvo
The first patients have enrolled in a major late-stage clinical trial testing the arthritis drug Actemra as a potential coronavirus treatment, Business Insider has learned. The study will ultimately enroll 330 people globally and produce initial results in early summer. Participants have to have severe cases of COVID-19, marked by pneumonia and requiring hospitalization. Enrolled patients will randomly receive either an IV infusion of Actemra or a matching placebo. After a month, physicians will assess their clinical status on a seven-category scale to see if they improved or worsened. The trial will help answer if Actemra can provide a real benefit to severe COVID-19 patients, particularly after anecdotal reports of its efficacy have come out of China. So far, at least six patients have been enrolled at trial sites in the US and Spain, Mark Eisner, Genentech's global head of immunology, infectious disease and ophthalmology clinical development, told Business Insider on Monday. Genentech is a subsidiary of Swiss pharmaceutical company Roche. https://www.pmlive.com/pharma_news/fda_approves_roches_actemra_covid-19_trial_1329887 -
Covid-19 / SARS-Cov2 - naučne/medicinske informacije i analize
Sunshine State replied to wwww's topic in Društvo
The first Phase I trial for the drug, INO-4800, will involve 40 healthy volunteers. The first dosing is set for today. “Preclinical data, which have been shared with global regulatory authorities and submitted as part of the [investigational new-drug application], have shown promising immune-response results across multiple animal models,” the Plymouth Meeting, Pa., company said in a statement. Each participant in the trial will receive two doses four weeks apart, with results expected by late summer. -
Ili privremeni radnici, oni do 90 dana u EU, pa 90 u SRB - takvi sumnjam da imaju neko osiguranje u zemljama u kojima privremeno rade. Ja sam se zajebala, pa dosla na davno planirani put, dok jos nije ni bila frka - frka me zatekla ovde. Imam dodatno privatno nemacko osiguranje, koje me pokriva bilo gde, ali ne daj Boze da mi zatreba lecenje u Srbiji - sasvim sigurno nisam "nagrnula u Srbiju" zbog zdravstvenog sistema.